Longer term, their pipeline has another second growth wave through mezagitamab, elritercept, fazirsiran, TAK-928, and TAK-921 ...
USA: A clinical trial has found that combining tirzepatide with ixekizumab led to significant improvements in skin clearance ...
Celebrities may have glam squads and access to the best doctors and treatments in the world — and yet even they have skin ...
Aboard Air Force One (AFP) | 15/05/2026 - 13:11:51 | Trump says Xi 'feels strongly' Iran can't have nuclear weapon ...
Adults with moderate to severe psoriasis and overweight or obesity were more likely to achieve complete skin clearance plus ...
Arcutis Biotherapeutics is evolving into a specialized dermatology platform, leveraging ZORYVE's expanding indications, ...
While a health care provider like a dermatologist can diagnose you with psoriasis based on a skin exam and medical history, ...
Late-breaking oral presentation of Phase 3 envudeucitinib data in moderate-to-severe plaque psoriasis (PsO) at the 2026 American Academy of Dermatology (AAD) Annual Meeting demonstrating early and ...
USA: A new study has highlighted promising results for a targeted therapy in managing generalized pustular psoriasis (GPP), a ...
Tildrakizumab maintained efficacy and safety in obese patients with scalp psoriasis over 52 weeks. Find out more about the ...
Microbiologist Alexander Fleming’s 80-year-old advice is still key to protecting the efficacy of antibiotics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results